Active Immunotherapy: Ready For Prime Time by admin | Jul 23, 2026 | Investor Presentations, Investors
Scancell and Neuphoria Therapeutics Announce Merger Agreement and Financing by admin | Jul 23, 2026 | Latest News, Regulatory News
Edison Report – Redesigning immunity: The next frontier in immuno-oncology by admin | Mar 4, 2026 | CircularsWelcome to WordPress. This is your first post. Edit or delete it, then start writing!
Scancell’s new partnership with the NHS Vaccine Launch Pad (CLVP) March 2025 by admin | Apr 14, 2025 | Investor Presentations
